Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,952,720
-$705,553 QoQ
Shares Held
247,206
+4.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#546
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EP Wealth Advisors, LLC holds $468,870,808 across 14 Drug Manufacturers - General names. PFE ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
708,767 | $180,005,554 | |
| 2 | LLY |
ELI LILLY & Co
|
96,123 | $115,292,819 | |
| 3 | ABBV |
AbbVie Inc.
|
297,328 | $74,819,617 | |
| 4 | MRK |
Merck & Co., Inc.
|
282,377 | $36,285,444 | |
| 5 | AMGN |
Amgen Inc
|
70,291 | $25,453,776 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
113,192 | $14,300,677 | |
| 7 | NVS |
Novartis AG
|
38,592 | $6,048,138 | |
| 8 | PFE |
Pfizer Inc
This page
|
247,206 | $5,952,720 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,952,720 | 247,206 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,658,273 | 237,118 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,442,476 | 258,734 | Shares | Sole | 2026-02-18 | |
| 2025-06-30 | $6,703,644 | 276,553 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,078,652 | 279,347 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,192,490 | 308,801 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,171,230 | 316,905 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $9,380,043 | 335,241 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $9,325,720 | 336,062 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,592,770 | 333,198 | Shares | Sole | 2024-02-28 | |
| 2023-09-30 | $12,011,719 | 362,126 | Shares | Sole | 2023-11-24 | |
| 2023-06-30 | $119,210 | 3,250 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,830,000 | 289,951 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $8,229,861 | 160,614 | Shares | Sole | 2023-06-12 | |
| 2022-09-30 | $6,419,373 | 146,695 | Shares | Sole | 2022-12-02 | |
| 2022-06-30 | $5,647,864 | 107,722 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,975,148 | 96,101 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $5,907,421 | 100,041 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $4,146,250 | 96,402 | Shares | Sole | 2021-11-23 | |
| 2021-06-30 | $3,885,416 | 99,219 | Shares | Sole | 2021-08-24 | |
| 2021-03-31 | $3,577,893 | 98,755 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,543,072 | 96,253 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $3,269,306 | 89,082 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $2,794,708 | 85,465 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,215,753 | 98,522 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||